Ribbon Acquisition Q2 FY26 net loss narrows to $19,601; six-month net income rises to $233,154
RIBB•Quarterly results
Ribbon Acquisition posted a net loss of $19,601 for the quarter ended June 30, 2026, on operating expenses of $338,611.
Income from marketable securities held in the Trust Account totaled $319,010, offsetting most costs during the quarter.
Business combination update
Business combination efforts remained focused on DRC Medicine; shareholders extended the deal deadline to Jan. 16, 2027.
Six-month results and liquidity
For the six months ended June 30, 2026, net income was $233,154, with $649,551 of Trust Account investment income.
Working capital deficit stood at $1.8 million as of June 30, 2026, with net cash used in operating activities of $88,766.
